NMTCB study guide Graded A+

Patient Release (therapy) - TEDE < 0.5rem (5mSv) TEDE to other individual < 0.1 rem (1mSv) with written instructions Palliative therapy: Sr-89 Chloride - Ca+ analog that rapidly clears out of blood and localizes in areas of osteogenesis repeated every 12 weeks Palliative therapy: Sm-153 Lexidronam - BONE CANCER phosphate compound repeat t(x) every 12 weeks Palliative therapy: P-32 Sodium Phosphate - BONE CANCER accumulation in hydroxiapatite crytal of bone and non-osseous tissue Repeat every 12 weeks Palliative Therapy: Y-90 Zevalin - Monoclonal antibody Radioimmunotherapy for Non-Hodgkin's lymphoma Rituximab infusion Zevalin 10 min infusion Dose < 32mCi Palliative Therapy: Y-90 Microspheres - LIVER CANCERglass microspheres (20-30um) MAA shunting prior to therapy Palliative Therapy: Ra-223 Dichloride (Xofigo) - Prostate cancer administration every 4 weeks for 6 weeks (6 injections) Wipe test trigger level - 22,000dpm/100cm^2 RSO must be notified